(Q44630959)

English

Streptococcus equi antigens adsorbed onto surface modified poly-epsilon-caprolactone microspheres induce humoral and cellular specific immune responses

scientific article published on 17 June 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Streptococcus equi antigens adsorbed onto surface modified poly-epsilon-caprolactone microspheres induce humoral and cellular specific immune responses (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

1 reference

based on heuristic

inferred from title

Streptococcus equi

object named as

Streptococcus equi

1 reference

based on heuristic

inferred from title

Helena F. Florindo

1

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Lídia M. Gonçalves

3

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

António J. Almeida

5

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

author name string

S Pandit

2

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

H O Alpar

4

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

language of work or name

0 references

publication date

17 June 2008

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

33

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

4168-4177

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Recombinant Streptococcus equi proteins protect mice in challenge experiments and induce immune response in horses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.074

7 January 2021

Getting a grip on strangles: recent progress towards improved diagnostics and vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.074

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.074

7 January 2021

Identification of lipoprotein homologues of pneumococcal PsaA in the equine pathogens Streptococcus equi and Streptococcus zooepidemicus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.074

7 January 2021

New advances in microsphere-based single-dose vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.074

7 January 2021

Particulate delivery systems for vaccines: what can we expect?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.074

7 January 2021

Recent advances in vaccine adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.074

7 January 2021

Revisiting PLA/PLGA microspheres: an analysis of their potential in parenteral vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.074

7 January 2021

Diphtheria toxoid loaded poly-(epsilon-caprolactone) nanoparticles as mucosal vaccine delivery systems

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.074

7 January 2021

Intranasal vaccination against plague, tetanus and diphtheria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.074

7 January 2021

Protection against Streptococcus equi infection by monoclonal antibodies against an M-like protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.074

7 January 2021

Microencapsulation of Streptococcus equi antigens in biodegradable microspheres and preliminary immunisation studies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.074

7 January 2021

Dynamic behavior of adsorber membranes for protein recovery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.074

7 January 2021

Tissue response to biodegradable injectable microcapsules

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.074

7 January 2021

Influence of various technological parameters on the preparation of spray-dried poly(epsilon-caprolactone) microparticles containing a model antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.074

7 January 2021

Preparation and characterization of protein-loaded poly(epsilon-caprolactone) microparticles for oral vaccine delivery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.074

7 January 2021

Stability study of nanoparticles of poly(epsilon-caprolactone), poly(D,L-lactide) and poly(D,L-lactide-co-glycolide)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.074

7 January 2021

Protein release from poly(epsilon-caprolactone) microspheres prepared by melt encapsulation and solvent evaporation techniques: a comparative study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.074

7 January 2021

Influences of process parameters on nanoparticle preparation performed by a double emulsion pressure homogenization technique

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.074

7 January 2021

A Brucella ovis antigenic complex bearing poly-epsilon-caprolactone microparticles confer protection against experimental brucellosis in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.074

7 January 2021

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.074

7 January 2021

MHC class I- and class II-restricted processing and presentation of microencapsulated antigens.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.074

7 January 2021

Parameters affecting the immunogenicity of microencapsulated tetanus toxoid

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.074

7 January 2021

The preparation and characterization of poly(lactide-co-glycolide) microparticles. II. The entrapment of a model protein using a (water-in-oil)-in-water emulsion solvent evaporation technique

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.074

7 January 2021

Biodegradable monodispersed nanoparticles prepared by pressure homogenization-emulsification

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.074

7 January 2021

Physicochemical evaluation of PLA nanoparticles stabilized by water-soluble MPEO-PLA block copolymers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.074

7 January 2021

Competitive adsorption of model charged proteins: the effect of total charge and charge distribution.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.074

7 January 2021

The protective M proteins of the equine group C streptococci

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.074

7 January 2021

Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.074

7 January 2021

Controlled delivery of diphtheria toxoid using biodegradable poly(D,L-lactide) microcapsules

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.074

7 January 2021

Development of a single dose tetanus toxoid formulation based on polymeric microspheres: a comparative study of poly(D,L-lactic-co-glycolic acid) versus chitosan microspheres

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.074

7 January 2021

Overview of new vaccines and technologies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.074

7 January 2021

Induction of cellular immunity to a mycobacterial antigen adsorbed on lamellar particles of lactide polymers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.074

7 January 2021

Mucosal nasopharyngeal immune responses of horses to protein antigens of Streptococcus equi.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.074

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of the sequences and functions of Streptococcus equi M-like proteins SeM and SzPSe.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.074

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular analysis of the M protein of Streptococcus equi and cloning and expression of the M protein gene in Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.074

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2008.05.074

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44630959&oldid=2153736818"